Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.

Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.

An improved number of anti-fungal drugs are currently available for the treatment of invasive aspergillosis (IA). While serial galactomannan index (GMI) measurement can be used to monitor response to treatment, the extent to which different anti-fungal regimens can affect galactomannan levels is unk...

Full description

Bibliographic Details
Main Authors: Louis Yi Ann Chai, Bart Jan Kullberg, Arul Earnest, Elizabeth M Johnson, Steven Teerenstra, Alieke G Vonk, Haran T Schlamm, Raoul Herbrecht, Mihai G Netea, Peter F Troke
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3938651?pdf=render

Internet

http://europepmc.org/articles/PMC3938651?pdf=render

Similar Items